Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06516653 · ClinicalTrials.gov registry record · NA
Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
A NA study of End Stage Renal Disease, sponsored by Laminate Medical Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 7
- Study locations
NCT06516653: Recruiting NA study of End Stage Renal Disease, sponsored by Laminate Medical Technologies.
NCT06516653 is a NA study of End Stage Renal Disease that is actively recruiting participants, run by Laminate Medical Technologies. The registered enrollment target is 300 participants, below the 830-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (64% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06516653, a NA study of End Stage Renal Disease, is actively recruiting participants, sponsored by Laminate Medical Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 7
- Study locations
Study Summary
VasQ is an external support implant for arteriovenous fistulas created for dialysis access. This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms: * Treatment arm: End to side fistula supported with VasQ * Control: Standard of care end to side fistula
Primary Outcome
The time, in days, to the first day of a 28-day period in which the study fistula was able to be cannulated with two dialysis needles for at least 75% of dialysis sessions to achieve the prescribed dialysis
Conditions Studied
Interventions
- DEVICE VasQ
- PROCEDURE Arteriovenous fistula creation for dialysis vascular access
Study Locations (7)
California
- Fresenius Vascular Care Long Beach - Long Beach
Florida
- Sarasota Memorial Hospital - Sarasota
Massachusetts
- Brigham and Women's Hospital - Boston
Mississippi
- Greenwood Leflore Hospital - Greenwood
Nevada
- Azura Surgery Center Las Vegas - Las Vegas
South Carolina
- Fresenius Vascular Care Columbia - Columbia
Virginia
- Fairlawn Surgery Center - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-01-13 |
| Est. Completion | 2028-05 |
| Phase | NA |
What NCT06516653 shows while recruiting
NCT06516653 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 830-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (64% lower).
The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 2 interventions - of which VasQ is the first listed.
NCT06516653 lists 7 locations in 7 states (California, Florida, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT06516653 about?
NCT06516653 is a clinical study titled "Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula". VasQ is an external support implant for arteriovenous fistulas created for dialysis access. This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms: * Treatment arm: End to side fistula supported w...
What is the current status of trial NCT06516653?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-01-13. Estimated completion is 2028-05.
What conditions does trial NCT06516653 study?
This clinical trial studies the following conditions: End Stage Renal Disease.
What interventions are being tested in trial NCT06516653?
The interventions under investigation include: VasQ (DEVICE), Arteriovenous fistula creation for dialysis vascular access (PROCEDURE).
Who is sponsoring clinical trial NCT06516653?
This trial is sponsored by Laminate Medical Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06516653 being conducted?
This trial has 7 study locations across California, Florida, Massachusetts, Mississippi, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06516653's enrollment target sits among peer trials
300 16th of 86 higher than 70 of 86 other End Stage Renal Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End Stage Renal Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
RECRUITING · NA
-
CAPABLE Transplant
RECRUITING · NA
-
Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI